Əsas səhifə

Çap

Əks əlaqə

İnfo
Structured telephone support or telemonitoring for chronic heart failure

Mündəricat

Structured telephone support or telemonitoring for chronic heart failure

Sübutlu məlumatların xülasələri
30.10.2017 • Sonuncu dəyişiklik 30.10.2017
Editors

Structured telephone support and telemonitoring appear to reduce all-cause mortality and heart failure-related hospitalizations in patients with chronic heart failure, and they also may improve quality of life and reduce costs.

A Cochrane review included 25 studies and 5 published abstracts. Of the 25 full peer-reviewed studies meta-analysed, 16 evaluated structured telephone support (n=5613), 11 evaluated telemonitoring (n=2710), and 2 tested both interventions (included in counts). Programmes were classified as structured telephone support if the monitoring and/or self-care management was delivered using simple telephone technology and telemonitoring if there was digital/broadband/satellite/wireless or blue-tooth transmission of physiologic and other non-invasive data. Telemonitoring reduced all-cause mortality (RR 0.66, 95% CI 0.54 to 0.81; 11 studies, n=2710) with structured telephone support demonstrating a non-significant positive effect (RR 0.88, 95% CI 0.76 to 1.01; 15 studies, n=5563). Both structured telephone support (RR 0.77, 95% CI 0.68 to 0.87; 13 studies, n=4269) and telemonitoring (RR 0.79, 95% CI 0.67 to 0.94; 4 studies, n=1570) reduced chronic heart failure (CHF)-related hospitalisations. For both interventions, several studies improved quality of life, reduced healthcare costs and were acceptable to patients. Improvements in prescribing, patient knowledge and self-care, and New York Heart Association (NYHA) functional class were observed.

Comment: The quality of evidence is downgraded by study quality (inadequate or unclear allocation concealment and blinding).

Ədəbiyyat

  1. Inglis SC, Clark RA, McAlister FA, Ball J, Lewinter C, Cullington D, Stewart S, Cleland JG. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev 2010;(8):CD007228.